Respiratory tract infections in children with congenital heart disease
Respiratory Syncytial Virus (RSV) infection is common among young children. Congenital Heart Disease (CHD) is a risk factor of severe illness and hospitalization. Palivizumab prophylaxis reduces the severity of RSV infection and reduces the risk of hospitalization for children at high risk of severe...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Umeå universitet, Pediatrik
2016
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-128024 http://nbn-resolving.de/urn:isbn:978-91-7601-589-6 |